ESMO Preceptorship on Lymphoma Madrid 2016

Oncology Meeting Resources

25 Nov - 26 Nov, Madrid, Spain

ESMO Preceptorship on Lymphoma square image

Main learning objectives for the ESMO Preceptorship on Lymphoma Madrid 2016 included highlighting the pathological bases of the most recent lymphoma classification, understanding the role of PET in staging, re-staging and follow-up, reviewing the treatment strategy for the most common lymphoma types, dissecting the peculiarities of lymphomas arising in particular extranodal sites, illustrating special and innovative treatment strategies and discussing clinical cases between faculty and participants.

Presentations from the Preceptorship are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links

Presenter Presentation title Session title
L. Quintanilla-Fend, DE Methods Used to Diagnose Lymphoma Session 1 Pathology and Staging
M. Ghielmini, CH CNS Lymphoma Session 1 Pathology and Staging
E. Bizgan, FR Nodular Lymphocyte - Predominant Hodgkin’s Lymphoma (NLPHL) - A clinical Case Session 1 Pathology and Staging
A. Martynchyk, UA Pancreatic Involvement by Primary Mediastinal Lymphoma Presenting as Acute Pancreatitis Session 1 Pathology and Staging
E. Campo, ES Pathology of the Indolent Lymphoid Neoplasms Session 2 Indolent
M. Ghielmini, CH Treatment of Follicular Lymphoma Session 2 Indolent
M. Dreying, DE Management of Mantle Cell Lymphoma Session 4 Mantle Cell and Extranodal
S. Montoto, UK MALT Lymphoma Session 4 Mantle Cell and Extranodal
M. Hutchings, DK Role of PET in Staging and Treatment of Lymphomas Session 4 Mantle Cell and Extranodal
B. Kiesewetter, AT A Case of Advanced Gastric MALT Lymphoma with Early Transformation to Aggressive B-Cell Lymphoma Session 4 Mantle Cell and Extranodal
B. Malaj, AL Bone Non- Hodgking Lymphoma Session 4 Mantle Cell and Extranodal
M. Provencio-Pulla, ES Treatment of Early Stage Session 6 Hodgkin
M. Hutchings, DK Treatment of Advanced Stage Session 6 Hodgkin
L. Specht, DK Prevention and Screening of Long Term Side Effects Session 6 Hodgkin
D. Pérez-Callejo, ES Long Lasting Complete Response with Nivolumab in a Refractory Patient Session 6 Hodgkin